Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
7.85
+0.07 (0.90%)
Jan 17, 2025, 4:00 PM EST - Market closed
Zenas BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Jan '25 Jan 17, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 328 | - | - |
| Enterprise Value | -58 | - | - |
| Debt / Equity Ratio | 0.00 | 0.87 | 0.03 |
| Asset Turnover | - | 0.70 | - |
| Quick Ratio | 8.79 | 2.44 | 2.59 |
| Current Ratio | 8.95 | 2.57 | 2.64 |
| Return on Equity (ROE) | -63.33% | -102.89% | - |
| Return on Assets (ROA) | -34.13% | -23.77% | - |
| Return on Capital (ROIC) | -38.80% | -35.79% | - |
| Buyback Yield / Dilution | -103.87% | -2.62% | - |
| Total Shareholder Return | -103.87% | -2.62% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.